MAP2 and central nervous system cancer: Nevertheless, the NGS genes PTPRS, MAP2, and CADM1 were expressed in most malignant cells across these gliomas (Figures 2A, B), consistent with the observed neurological associations of these genes (Zhou et al., 2015; Hendriks et al., 2018; Pan et al., 2020).